Amer Shared Hosp Financials
This page shows Amer Shared Hosp (AMS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
American Shared Hospital Services looks like a capital-heavy operator whose cash cushion shrank as unit economics weakened materially.
Recently, headline deleveraging did not create balance-sheet slack: long-term debt fell to$0 while cash dropped to$3.5M . The real shift was toward near-term pressure, with the current ratio sliding from 2.5x to 0.8x, so lower leverage on paper came with less day-to-day liquidity.
Volume was not the main problem: revenue held near
Cash conversion was better than the income statement alone suggests, as the latest year turned a net loss of
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Amer Shared Hosp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Amer Shared Hosp has an operating margin of -12.8%, meaning the company retains $-13 of operating profit per $100 of revenue. This below-average margin results in a low score of 2/100, suggesting thin profitability after operating expenses. This is down from -9.9% the prior year.
Amer Shared Hosp's revenue declined 0.9% year-over-year, from $28.3M to $28.1M. This contraction results in a growth score of 58/100.
Amer Shared Hosp carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
Amer Shared Hosp's current ratio of 0.76 is below the typical benchmark, resulting in a score of 10/100. This tight liquidity could limit financial flexibility if cash inflows slow.
While Amer Shared Hosp generated $3.1M in operating cash flow, capex of $7.6M consumed most of it, leaving -$4.5M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Amer Shared Hosp generates a -6.5% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 11/100. This is down from 8.7% the prior year.
Amer Shared Hosp passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Amer Shared Hosp generates $-1.99 in operating cash flow ($3.1M OCF vs -$1.6M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Amer Shared Hosp earns $-2.3 in operating income for every $1 of interest expense (-$3.6M vs $1.6M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Amer Shared Hosp generated $28.1M in revenue in fiscal year 2025. This represents a decrease of 0.9% from the prior year.
Amer Shared Hosp's EBITDA was $2.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 36.9% from the prior year.
Amer Shared Hosp reported -$1.6M in net income in fiscal year 2025. This represents a decrease of 171.0% from the prior year.
Amer Shared Hosp earned $-0.23 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 169.7% from the prior year.
Cash & Balance Sheet
Amer Shared Hosp generated -$4.5M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 41.6% from the prior year.
Amer Shared Hosp held $3.5M in cash against $0 in long-term debt as of fiscal year 2025.
Amer Shared Hosp had 7M shares outstanding in fiscal year 2025. This represents an increase of 2.3% from the prior year.
Margins & Returns
Amer Shared Hosp's gross margin was 18.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 14.4 percentage points from the prior year.
Amer Shared Hosp's operating margin was -12.8% in fiscal year 2025, reflecting core business profitability. This is down 2.9 percentage points from the prior year.
Amer Shared Hosp's net profit margin was -5.5% in fiscal year 2025, showing the share of revenue converted to profit. This is down 13.2 percentage points from the prior year.
Amer Shared Hosp's ROE was -6.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 15.1 percentage points from the prior year.
Capital Allocation
Amer Shared Hosp invested $7.6M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 3.8% from the prior year.
AMS Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.1M-8.3% | $7.7M+7.8% | $7.2M+1.4% | $7.1M+15.7% | $6.1M-32.6% | $9.1M+29.6% | $7.0M-0.8% | $7.1M |
| Cost of Revenue | $5.8M-15.0% | $6.8M+22.1% | $5.6M+2.6% | $5.4M+5.2% | $5.2M-11.8% | $5.9M+4.2% | $5.6M+22.7% | $4.6M |
| Gross Profit | $1.3M+42.2% | $906K-42.9% | $1.6M-2.7% | $1.6M+73.0% | $942K-70.6% | $3.2M+133.9% | $1.4M-44.5% | $2.5M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $1.9M-3.8% | $2.0M+29.1% | $1.5M-11.9% | $1.7M-3.4% | $1.8M+5.8% | $1.7M-11.1% | $1.9M+1.4% | $1.9M |
| Operating Income | -$924K+34.0% | -$1.4M-307.3% | -$344K+36.8% | -$544K+58.1% | -$1.3M+29.0% | -$1.8M-105.8% | -$889K-88800.0% | -$1K |
| Interest Expense | $302K-5.9% | $321K-18.1% | $392K-8.4% | $428K-1.2% | $433K+0.9% | $429K+27.7% | $336K-12.7% | $385K |
| Income Tax | $92K+146.7% | -$197K-510.4% | $48K+328.6% | -$21K+93.5% | -$323K-533.3% | -$51K+69.8% | -$169K-445.2% | -$31K |
| Net Income | -$612K+3.0% | -$631K-3611.8% | -$17K+93.9% | -$280K+55.2% | -$625K+52.9% | -$1.3M-541.5% | -$207K-105.7% | $3.6M |
| EPS (Diluted) | $-0.09 | N/A | $0.00+100.0% | $-0.04+60.0% | $-0.10 | N/A | $-0.03-105.5% | $0.55 |
AMS Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $54.7M-1.4% | $55.5M-7.0% | $59.6M-6.1% | $63.5M+0.3% | $63.3M+5.2% | $60.2M-4.9% | $63.3M+4.0% | $60.8M |
| Current Assets | $18.3M+3.1% | $17.7M-13.9% | $20.6M-15.7% | $24.4M+2.9% | $23.7M-9.6% | $26.3M+2.1% | $25.7M+0.3% | $25.6M |
| Cash & Equivalents | $5.0M+43.6% | $3.5M-32.1% | $5.1M-54.0% | $11.1M-1.4% | $11.2M+2.0% | $11.0M-20.3% | $13.8M-2.9% | $14.2M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $10.6M+0.4% | $10.5M-10.9% | $11.8M+23.3% | $9.6M+9.6% | $8.7M-24.7% | $11.6M+34.5% | $8.6M+0.3% | $8.6M |
| Goodwill | $1.3M0.0% | $1.3M0.0% | $1.3M0.0% | $1.3M0.0% | $1.3M0.0% | $1.3M0.0% | $1.3M0.0% | $1.3M |
| Total Liabilities | $28.0M+0.8% | $27.8M-10.4% | $31.0M-10.4% | $34.6M+1.6% | $34.1M+13.0% | $30.2M-4.0% | $31.4M+10.4% | $28.5M |
| Current Liabilities | $23.7M+1.2% | $23.4M-9.1% | $25.8M+23.7% | $20.9M+64.1% | $12.7M+22.2% | $10.4M-40.7% | $17.6M+31.7% | $13.3M |
| Long-Term Debt | $16.8M | $0 | $0-100.0% | $9.2M-45.1% | $16.8M-3.1% | $17.3M+60.3% | $10.8M-10.2% | $12.1M |
| Total Equity | $23.5M-2.1% | $24.0M-2.2% | $24.6M+0.3% | $24.5M-0.7% | $24.6M-2.1% | $25.2M-4.7% | $26.4M-0.4% | $26.5M |
| Retained Earnings | $3.6M-14.4% | $4.3M-12.9% | $4.9M-0.3% | $4.9M-5.4% | $5.2M-10.7% | $5.8M-18.6% | $7.1M-2.8% | $7.3M |
AMS Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.1M+405.3% | -$704K-142.1% | $1.7M+549.2% | -$372K-114.9% | $2.5M+813.5% | $274K-41.9% | $472K-63.3% | $1.3M |
| Capital Expenditures | $41K+102.1% | -$2.0M-153.6% | $3.7M+94.7% | $1.9M-52.7% | $4.0M-13.8% | $4.7M+430.1% | $879K-27.7% | $1.2M |
| Free Cash Flow | $2.1M+178.4% | -$2.7M-32.3% | -$2.0M+10.6% | -$2.3M-50.3% | -$1.5M+65.5% | -$4.4M-977.6% | -$407K-681.4% | $70K |
| Investing Cash Flow | -$41K-102.1% | $2.0M+153.6% | -$3.7M-94.7% | -$1.9M+52.7% | -$4.0M+8.0% | -$4.4M-520.0% | -$704K+17.5% | -$853K |
| Financing Cash Flow | -$597K+79.5% | -$2.9M+26.3% | -$4.0M-287.2% | $2.1M+22.3% | $1.7M+34.1% | $1.3M+828.2% | -$177K-117.5% | $1.0M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
AMS Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 18.2%+6.5pp | 11.7%-10.4pp | 22.1%-0.9pp | 23.1%+7.6pp | 15.4%-19.9pp | 35.3%+15.8pp | 19.6%-15.4pp | 35.0% |
| Operating Margin | -13.0%+5.1pp | -18.1%-13.3pp | -4.8%+2.9pp | -7.7%+13.6pp | -21.3%-1.1pp | -20.2%-7.5pp | -12.7%-12.7pp | -0.0% |
| Net Margin | -8.6%-0.5pp | -8.2%-7.9pp | -0.2%+3.7pp | -4.0%+6.3pp | -10.2%+4.4pp | -14.6%-11.7pp | -3.0%-54.0pp | 51.0% |
| Return on Equity | -2.6%+0.0pp | -2.6%-2.6pp | -0.1%+1.1pp | -1.1%+1.4pp | -2.5%+2.7pp | -5.3%-4.5pp | -0.8%-14.3pp | 13.6% |
| Return on Assets | -1.1%+0.0pp | -1.1%-1.1pp | -0.0%+0.4pp | -0.4%+0.6pp | -1.0%+1.2pp | -2.2%-1.9pp | -0.3%-6.3pp | 5.9% |
| Current Ratio | 0.77+0.0 | 0.76-0.0 | 0.80-0.4 | 1.17-0.7 | 1.87-0.7 | 2.52+1.1 | 1.46-0.5 | 1.92 |
| Debt-to-Equity | 0.72+0.7 | 0.000.0 | 0.00-0.4 | 0.38-0.3 | 0.680.0 | 0.69+0.3 | 0.41-0.0 | 0.45 |
| FCF Margin | 29.8%+64.5pp | -34.8%-6.5pp | -28.3%+3.8pp | -32.1%-7.4pp | -24.7%+23.6pp | -48.4%-42.5pp | -5.8%-6.8pp | 1.0% |
Note: The current ratio is below 1.0 (0.76), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
